Zhao SY, Liu Z, Pu
But with Zepbound , not losing weight can mean a few different things, and not all of them signal a problem
Semaglutide face, AKA Wegovy face, Mounjaro face, or even just weight loss face, can occur after losing weight
[3] [4] Tirzepatide represents a novel pharmacological approach as the first dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist approved for weight management, distinguishing it from single-mechanism GLP-1 agonists
However, hypoalbuminemic patients experienced a markedly higher rate of therapy discontinuation due to documented toxicities, potentially attributable to either more severe adverse effects or a compromised functional status in this cohort
What results can I expect from GLP-1 weight loss medications